For Doctors in a Hurry
- Clinicians lack a clear understanding of the cellular mechanisms driving vascular hyalinization in patients with unicentric Castleman disease and paraneoplastic pemphigus.
- The researchers performed bulk RNA sequencing on 33 patients and single-cell RNA sequencing on 58,811 cells from lymph node samples.
- Analysis revealed endothelial cells drive collagen overproduction via COL4A1 signaling, which directly correlates with vascular basement membrane accumulation and inflammation.
- The authors conclude that endothelial cell expansion and aberrant stromal-immune crosstalk are the primary drivers of disease pathogenesis.
- Targeting these specific endothelial-B cell interactions may provide a future therapeutic strategy to manage this high-mortality condition.
The Lethal Intersection of Lymphoproliferation and Autoimmunity
Unicentric Castleman disease is a rare lymphoproliferative disorder that typically carries an excellent prognosis following complete surgical resection [1, 2, 3]. However, the clinical trajectory shifts dramatically when the disease is complicated by paraneoplastic pemphigus, a severe autoimmune mucocutaneous syndrome characterized by high mortality and life-threatening respiratory failure [4, 5]. In a retrospective study of 281 patients, bronchiolitis obliterans (an obstructive lung disease caused by small airway inflammation) occurred in 6.4% of cases and was associated with an 83.3% prevalence of paraneoplastic pemphigus [6]. While the hyaline-vascular histological subtype is the most common variant, current interventions often fail to halt the progression of pulmonary damage, as complete surgical resection does not consistently prevent the advancement of respiratory failure [7, 6, 8]. A recent transcriptomic analysis (a method used to study the complete set of RNA transcripts in a cell) of 33 patients now identifies aberrant endothelial cell expansion and extracellular matrix dysregulation as primary drivers of the vascular hyalinization and systemic immune dysfunction seen in these complex cases [4].
Mapping the Cellular Landscape of Hyaline-Vascular Lesions
To investigate the cellular drivers of this condition, researchers conducted bulk RNA sequencing (a technique that measures the average gene expression across a whole tissue sample) on lymph node specimens from 33 patients with pathologically confirmed Unicentric Castleman disease complicated by paraneoplastic pemphigus. In this specific patient cohort, the hyaline-vascular histological subtype was the predominant presentation, characterized by the dense, concentric layers of collagen and prominent vascularity that define the disease's morphology. The study further refined these findings by performing single-cell RNA sequencing (a high-resolution method that identifies the genetic profile of individual cells) on 58,811 cells derived from 5 of the 33 patients. To bridge the gap between individual cell data and the larger patient group, the authors utilized cellular deconvolution (a computational method used to estimate the proportions of different cell types within a bulk tissue sample). This analysis revealed a significant shift in the lymph node microenvironment, identifying a marked expansion of endothelial cells (the cells lining blood vessels), pericytes (contractile cells that wrap around capillaries and regulate blood flow), and fibroblasts within the Unicentric Castleman disease and paraneoplastic pemphigus samples. Conversely, there was a notable diminution of follicular dendritic cells, the specialized immune cells responsible for organizing B-cell follicles and presenting antigens, which may explain the architectural breakdown of the lymph node.
The bulk RNA sequencing analysis of the lymph node samples provided a high-level view of the molecular landscape in Unicentric Castleman disease complicated by paraneoplastic pemphigus. The researchers identified a significant upregulation of collagen genes, a finding that serves as a molecular signature for extracellular matrix dysregulation (the abnormal accumulation or structural reorganization of the supportive proteins surrounding cells). This genetic profile aligns with the characteristic histological features of the disease, where the overproduction of structural proteins leads to the progressive architectural distortion of the lymph node. To pinpoint the cellular source of this protein accumulation, the study utilized cell-cell communication analysis (a computational method that predicts how different cell types interact based on their gene expression). This analysis identified endothelial cells as the primary contributors to the overproduction of collagen and laminin. Specifically, the researchers found that the overproduction of the extracellular matrix is mediated through two distinct molecular pathways: COL4A1-ITGA1/ITGB1 and LAMB1-ITGA6/ITGB1 signaling. These pathways involve the interaction between collagen or laminin and their corresponding integrin receptors on target cells. This specific signaling mechanism directly links endothelial cell activity to perivascular hyalinization, which is the clinical observation of thickening and scarring within the blood vessel walls. The study further demonstrated that the overexpression of COL4A1 (a gene encoding a subunit of type IV collagen) within endothelial cells upregulated a suite of genes involved in extracellular matrix organization and remodeling. Ultimately, the pathogenesis centers on aberrant endothelial cell expansion and dysregulation, which drives vascular hyalinization through excessive deposition of the extracellular matrix. For the clinician, these findings suggest that the characteristic vascular changes seen on biopsy are the direct result of a specific endothelial-driven molecular program.
Pathological Crosstalk Between Vasculature and B Cells
The immune landscape of Unicentric Castleman disease complicated by paraneoplastic pemphigus is characterized by a profound shift toward antibody production and chronic activation. The researchers identified marked plasmablast expansion (an increase in immature cells committed to antibody secretion) and evidence of IgG class-switching, the process by which B cells shift from producing early-phase antibodies to more specialized IgG subtypes. This heightened state of B-cell hyperactivity is not an isolated phenomenon; the study found that memory CD4+ T cells drive B-cell hyperactivity, suggesting a coordinated cellular effort that sustains the autoimmune response. A critical discovery was the identification of a direct molecular bridge between the expanding vasculature and these hyperactive immune cells. Using ligand-receptor analysis (a method that identifies pairs of proteins that allow cells to communicate), the researchers revealed a pivotal interaction between endothelial cell-derived COL4A1 and the CD44 receptor on B cells. This interaction demonstrates that the structural components of the blood vessels are not merely scaffolding but are active signaling hubs. To validate the functional impact of this cellular communication, the researchers performed a proteomic analysis of functional co-cultures (the large-scale study of proteins secreted when endothelial cells and B cells are grown together). This analysis showed that endothelial-B cell crosstalk drives vascular basement membrane accumulation, specifically the deposition of Perlecan (also known as HSPG2), a large proteoglycan that contributes to the thickening of the vessel wall. Beyond structural changes, this interaction also drives the release of the pro-inflammatory cytokine CCL4. These pathological endothelial-B cell interactions provide a clear mechanistic link between the accumulation of the basement membrane and the pro-inflammatory signaling that defines the systemic illness. For physicians, this clarifies that the hyaline-vascular changes seen on a biopsy are functionally coupled with the cytokine release that fuels the patient's systemic symptoms, suggesting that targeting this endothelial-immune crosstalk may be necessary to manage the autoimmune complications.
References
1. Shen J, Zeng Y, Liu Y, Xu N. Retrospective analysis of primary extranodal unicentric Castleman disease: a systematic review. Frontiers in Medicine. 2026. doi:10.3389/fmed.2026.1749931
2. Rhee FV, Oksenhendler É, Srkalović G, et al. International evidence-based consensus diagnostic and treatment guidelines for unicentric Castleman disease. Blood Advances. 2020. doi:10.1182/bloodadvances.2020003334
3. Mitsos S, Stamatopoulos A, Patrini D, George R, Lawrence D, Panagiotopoulos N. The Role of Surgical Resection in Unicentric Castleman’s Disease: A Systematic Review. Advances in respiratory medicine. 2018. doi:10.5603/arm.2018.0008
4. Wang S, Wang R, Yang Y, et al. Transcriptomic profile reveals cellular composition contribute to hyaline-vascular variant in unicentric Castleman disease-associated paraneoplastic pemphigus.. The British journal of dermatology. 2026. doi:10.1093/bjd/ljag153
5. Dieudonné Y, Silvestrini M, Dossier A, et al. Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease. British Journal of Haematology. 2023. doi:10.1111/bjh.18847
6. Liu Y, Zhen J, Gao Y, et al. Unicentric Castleman disease complicated with bronchiolitis obliterans: A single‐centre retrospective study from China. British Journal of Haematology. 2024. doi:10.1111/bjh.19966
7. Cen J, Zeng W, Pan M, Qiu Y, Zhang J. Multicentric Castleman disease of hyaline‑vascular variant with paraneoplastic pemphigus results in abnormal lung function: Report of 3 cases. Experimental and Therapeutic Medicine. 2023. doi:10.3892/etm.2023.11968
8. Chen R, Teng Y, Xiao Y, et al. Constrictive bronchiolitis and paraneoplastic pemphigus caused by unicentric Castleman disease in a young woman: a case report. Frontiers in Medicine. 2024. doi:10.3389/fmed.2024.1468251
